...We Welcome You To The Resverlogix HUB In The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: Eerily quiet....
and yet so much evidence that interest in epigenetics is heating up. To be clear this is pure speculation on my part but... I just wonder, I just wonder.... Happy 2016 everyone. Haven't been posting because I haven't got much to say right now. But am still long and strong. Here's hoping for a profitable year. tundup
Share
New Message
Please login to post a reply